We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $118M
This Fund
S&P 500
This Quarter Est. Return
+9.75%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$135M
AUM Growth
-$1.28M
Cap. Flow
-$11.4M
Cap. Flow %
-8.5%
Top 10 Hldgs %
21.49%
Holding
245
New
28
Increased
29
Reduced
140
Closed
15

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$2.85M
2
ATEC icon
Alphatec Holdings
ATEC
+$2.84M
3
INDV icon
Indivior Pharmaceuticals
INDV
+$2.84M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$2.12M
5
APLS
Apellis Pharmaceuticals
APLS
+$1.76M

Top Sells

Rank Stock Value
1
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$4.17M
2
PCRX icon
Pacira BioSciences
PCRX
+$3.36M
3
PFE icon
Pfizer
PFE
+$3.06M
4
UTHR icon
United Therapeutics
UTHR
+$2.79M
5
QURE icon
uniQure
QURE
+$2.06M

Sector Composition

Rank Sector Weight
1 Healthcare 57.92%
2 Real Estate 14.45%
3 Financials 7.05%
4 Industrials 3.2%
5 Technology 2.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LEN icon
176
Lennar Class A
LEN
$20.4B
$110K 0.08%
606
-22
-4% -$3.69K
EWL icon
177
iShares MSCI Switzerland ETF
EWL
$2.12B
$109K 0.08%
2,094
-118
-5% -$5.96K
EWO icon
178
iShares MSCI Austria ETF
EWO
$146M
$108K 0.08%
4,751
+119
+3% +$2.68K
STHO icon
179
Star Holdings Shares of Beneficial Interest
STHO
$112M
$107K 0.08%
7,744
– –
MET icon
180
MetLife
MET
$61B
$107K 0.08%
1,297
-41
-3% -$3.06K
WFC icon
181
Wells Fargo
WFC
$261B
$103K 0.08%
1,825
-58
-3% -$3.28K
LQD icon
182
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.7B
$101K 0.08%
898
-21
-2% -$2.32K
WIP icon
183
State Street SPDR FTSE International Government Inflation-Protected Bond ETF
WIP
$479M
$101K 0.08%
+2,514
New +$98.8K
SCHP icon
184
Schwab US TIPS ETF
SCHP
$16.3B
$101K 0.08%
3,770
-22
-0.6% -$581
MUB icon
185
iShares National Muni Bond ETF
MUB
$45.1B
$101K 0.07%
927
-1
-0.1% -$108
IGSB icon
186
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.8B
$101K 0.07%
1,909
-11
-0.6% -$572
FLRN icon
187
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$3.11B
$100K 0.07%
3,245
+60
+2% +$1.85K
FIX icon
188
Comfort Systems
FIX
$61B
$98K 0.07%
251
-7
-3% -$2.31K
CB icon
189
Chubb
CB
$140B
$97.5K 0.07%
338
-13
-4% -$3.56K
WRB icon
190
W.R. Berkley
WRB
$28B
$95.8K 0.07%
1,688
-64
-4% -$3.59K
PGR icon
191
Progressive
PGR
$124B
$92.1K 0.07%
363
-10
-3% -$2.33K
KKR icon
192
KKR & Co
KKR
$89.2B
$89.8K 0.07%
688
-18
-3% -$2.13K
MBOT icon
193
Microbot Medical
MBOT
$115M
$89.4K 0.07%
100,000
– –
ALL icon
194
Allstate
ALL
$66.9B
$89.3K 0.07%
471
-11
-2% -$1.95K
GM icon
195
General Motors
GM
$74.7B
$88.4K 0.07%
1,972
-78
-4% -$3.62K
AIG icon
196
American International
AIG
$41.9B
$87.4K 0.06%
1,193
-40
-3% -$2.98K
EME icon
197
Emcor
EME
$33.1B
$87K 0.06%
202
-6
-3% -$2.27K
BURL icon
198
Burlington
BURL
$22B
$86.9K 0.06%
330
-9
-3% -$2.33K
FCNCA icon
199
First Citizens BancShares
FCNCA
$24.6B
$84.7K 0.06%
46
-1
-2% -$1.91K
CMCSA icon
200
Comcast
CMCSA
$79.1B
$83.6K 0.06%
2,002
-62
-3% -$2.45K
6 7
8
9 10

Similar funds

AIS
Advocate Investing Services Woodbine, Maryland $118M AUM
IVGAI
Index Venture Growth Associates III St. Helier, Channel Islands, Jersey $118M AUM 64.91% 1-Year Est. Return
OIM
Oceanic Investment Management Douglas, Isle Of Man $118M AUM
TIP
Tandem Investment Partners Bordentown, New Jersey $118M AUM 15.76% 1-Year Est. Return
RCG
Ridge Creek Global Strongsville, Ohio $118M AUM
CWM
Capstone Wealth Management Billings, Montana $118M AUM
SPW
Stillwater Private Wealth Glen Mills, Pennsylvania $118M AUM
WLC
Walnut Level Capital Denver, Colorado $118M AUM 59.12% 1-Year Est. Return

AlphaCentric Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, AlphaCentric Advisors held 245 positions worth $135M, down 0.95% from $136M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

AlphaCentric Advisors withdrew a net $11.4M in Q3 2024, closing 15 positions and reducing 140 holdings. Its most notable exit was BioCryst Pharmaceuticals, an estimated $4.17M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 58% of assets, down from 60% a quarter earlier, followed by Real Estate and Financials.

Against the trend, AlphaCentric Advisors opened a new position in Merck worth $2.73M.

  • AlphaCentric Advisors's largest Q3 2024 buy was Merck: 24,000 shares worth $2.73M.
  • AlphaCentric Advisors added most to Neurocrine Biosciences in Q3 2024, an estimated $2.12M increase.
  • AlphaCentric Advisors's biggest Q3 2024 reduction was Pfizer, cutting an estimated $3.06M.
  • AlphaCentric Advisors fully exited BioCryst Pharmaceuticals in Q3 2024, selling an estimated $4.17M.
  • AlphaCentric Advisors's ten largest holdings make up 21% of its $135M portfolio in Q3 2024.
  • AlphaCentric Advisors opened 28 new positions and closed 15 in Q3 2024.
  • AlphaCentric Advisors's portfolio value fell 0.95% quarter-over-quarter to $135M.

Based on AlphaCentric Advisors's 13F filing for Q3 2024, filed 30 Oct 2024.